EUVIMEDEUVIMED entdecken
Crossref

Patient preferences and perceived barriers to follow-up care in a pharmacy-based colorectal cancer screening program: a national survey

Jessie Schwartz, Mary Wangen, Olufeyisayo O Odebunmi, Austin Waters, Renée Ferrari, Macary Marciniak, Alison T Brenner, Stephanie B Wheeler, Parth D Shah

Cancer Causes & Control · 2025

DOI: 10.1007/s10552-025-02045-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Causes & Control, 2025. Verfasst von Jessie Schwartz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, USA. jschwar2@fredhutch.org. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Patient Preference. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Fecal immunochemical tests (FIT) are recommended for routine colorectal cancer (CRC) screening because they are cost-effective, non-invasive, and convenient. Pharmacy-based CRC screening using FIT kits could be effective to improve screening rates, particularly in medically underserved communities. However, data on follow-up procedures and barriers after positive FIT results in this context remain sparse. METHODS: We conducted a national survey of 1,045 US adults aged 45-75 to assess preferences for follow-up care in a pharmacy-based CRC screening program we call PharmFIT™ and identify perceived barriers to follow-up colonoscopy after positive FIT results. We evaluated patient preferences and barriers using descriptive statistics. We used multinomial logistic regressions to identify correlates of patient preferences for follow-up and multiple logistic regressions to identify correlates of perceived psychosocial and structural barriers to follow-up colonoscopy. RESULTS: Participants showed a strong preference for digital communication for negative FIT results and reminders, but favored direct, interpersonal communication from healthcare providers for positive results and follow-up. Psychosocial barriers, such as fear of colonoscopy or cancer diagnosis, were more prevalent than structural barriers like cost and transportation. Older adults, those with a regular healthcare provider, and higher-income individuals were less likely to report barriers, while non-white and Medicaid patients showed lower preferences for automated notifications. CONCLUSION: PharmFIT should use tailored, multimodal communication strategies to address patient preferences and include strategies, like patient navigation, to address potential barriers to follow-up colonoscopy. This study reinforces the potential of pharmacy-based CRC screening programs to increase screening access and opportunities, particularly in medically underserved communities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerPatient PreferenceHumansMaleFemaleMiddle AgedAgedUnited StatesOccult BloodColonoscopySurveys and QuestionnairesMass ScreeningFollow-Up Studies

Stichwörter der Autor:innen

Colorectal cancer screeningImplementation sciencePharmacy

Autor:innen und Institutionen

  • Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, USA. jschwar2@fredhutch.org.
  • Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, Chapel Hill, USA.
  • UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA.
  • UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA.
  • School of Pharmacy, UNC Eshelman, University of North Carolina at Chapel Hill, Chapel Hill, USA.
  • UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA.

Zitieren

APA

Schwartz, J., Wangen, M., Odebunmi, O. O., Waters, A., Ferrari, R., Marciniak, M., Brenner, A. T., Wheeler, S. B., & Shah, P. D. (2025). Patient preferences and perceived barriers to follow-up care in a pharmacy-based colorectal cancer screening program: a national survey. Cancer Causes & Control. https://doi.org/10.1007/s10552-025-02045-9

Vancouver

Schwartz J, Wangen M, Odebunmi OO, Waters A, Ferrari R, Marciniak M, et al. Patient preferences and perceived barriers to follow-up care in a pharmacy-based colorectal cancer screening program: a national survey. Cancer Causes & Control. 2025. doi:10.1007/s10552-025-02045-9

BibTeX
@article{Schwartz2025,
  author = {Schwartz, Jessie and Wangen, Mary and Odebunmi, Olufeyisayo O and Waters, Austin and Ferrari, Renée and Marciniak, Macary and Brenner, Alison T and Wheeler, Stephanie B and Shah, Parth D},
  title = {Patient preferences and perceived barriers to follow-up care in a pharmacy-based colorectal cancer screening program: a national survey},
  journal = {Cancer Causes & Control},
  year = {2025},
  doi = {10.1007/s10552-025-02045-9}
}
Kostenlos starten →